Boenning & Scattergood, Inc. Novartis Ag Transaction History

Boenning & Scattergood, Inc.

$622 Million
Q4 2022

A detailed history of Boenning & Scattergood, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 5,798 shares of NVS stock, worth $604,615. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,798

Previous 5,796 0.03%

Holding current value

$604,615

Previous $441,000 15.42%

% of portfolio

0.08%

Previous 0.09%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$75.55 - $92.52 $151 - $185	2 Added 0.03%	5,798 $509,000
Q3 2022 Oct 11, 2022	SELL	$74.61 - $87.26 $522 - $610	-7 Reduced 0.12%	5,796 $441,000
Q2 2022 Jul 13, 2022	BUY	$80.52 - $93.75 $402 - $468	5 Added 0.09%	5,803 $491,000
Q1 2022 Apr 14, 2022	SELL	$80.11 - $90.62 $75,944 - $85,907	-948 Reduced 14.05%	5,798 $509,000
Q4 2021 Jan 18, 2022	BUY	$79.7 - $88.13 $39,850 - $44,065	500 Added 8.01%	6,746 $590,000
Q3 2021 Oct 21, 2021	BUY	$81.78 - $95.14 $61,335 - $71,355	750 Added 13.65%	6,246 $510,000
Q1 2021 Apr 22, 2021	BUY	$83.5 - $98.47 $24,465 - $28,851	293 Added 5.63%	5,496 $470,000
Q4 2020 Jan 20, 2021	BUY	$78.07 - $94.43 $3,122 - $3,777	40 Added 0.77%	5,203 $491,000
Q3 2020 Oct 21, 2020	BUY	$82.14 - $91.0 $4,599 - $5,096	56 Added 1.1%	5,163 $449,000
Q2 2020 Jul 14, 2020	SELL	$80.93 - $91.1 $52,928 - $59,579	-654 Reduced 11.35%	5,107 $446,000
Q1 2020 Apr 13, 2020	SELL	$70.67 - $99.01 $38,373 - $53,762	-543 Reduced 8.61%	5,761 $475,000
Q3 2019 Oct 15, 2019	SELL	$85.54 - $94.26 $342 - $377	-4 Reduced 0.06%	6,304 $548,000
Q1 2019 Apr 22, 2019	BUY	$75.32 - $86.15 $1,129 - $1,292	15 Added 0.24%	6,308 $606,000
Q3 2018 Oct 05, 2018	BUY	$66.94 - $77.43 $83,675 - $96,787	1,250 Added 24.79%	6,293 $542,000
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $327,341 - $369,954	5,043 New	5,043 $381,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.

Account

Boenning & Scattergood, Inc. Novartis Ag Transaction History